Identification of epoxybergamottin as a CYP3A4 inhibitor in grapefruit peel.
- Published in:
- European Journal of Clinical Pharmacology, 2003, v. 58, n. 10, p. 663, doi. 10.1007/s00228-002-0537-3
- By:
- Publication type:
- Article
Works matching IS 00316970 AND DT 2003 AND VI 58 AND IP 10
Results: 14
1
2
Raynaud's phenomenon induced by drugs acting on neurotransmission: two cases under reboxetine and one under tegaserod.
- Published in:
- European Journal of Clinical Pharmacology, 2003, v. 58, n. 10, p. 717, doi. 10.1007/s00228-002-0552-4
- By:
- Publication type:
- Article
3
Intrarectal pharmacokinetics of two formulations of quinine in children with falciparum malaria.
- Published in:
- European Journal of Clinical Pharmacology, 2003, v. 58, n. 10, p. 649, doi. 10.1007/s00228-002-0546-2
- By:
- Publication type:
- Article
4
Reporting adverse drug reactions on a geriatric ward: a pilot project.
- Published in:
- European Journal of Clinical Pharmacology, 2003, v. 58, n. 10, p. 707, doi. 10.1007/s00228-002-0535-5
- By:
- Publication type:
- Article
5
Pharmacokinetics and pharmacodynamics of rosuvastatin in subjects with hepatic impairment.
- Published in:
- European Journal of Clinical Pharmacology, 2003, v. 58, n. 10, p. 669, doi. 10.1007/s00228-002-0541-7
- By:
- Publication type:
- Article
6
The skin vasoconstrictor assay does not correlate significantly to airway or systemic responsiveness to inhaled budesonide in asthmatic patients.
- Published in:
- European Journal of Clinical Pharmacology, 2003, v. 58, n. 10, p. 643, doi. 10.1007/s00228-002-0547-1
- By:
- Publication type:
- Article
7
CYP2D6*10 alleles do not determine plasma fluvoxamine concentration/dose ratio in Japanese subjects.
- Published in:
- European Journal of Clinical Pharmacology, 2003, v. 58, n. 10, p. 659, doi. 10.1007/s00228-002-0529-3
- By:
- Publication type:
- Article
8
Initial 3-month usage characteristics predict long-term use of benzodiazepines: an 8-year follow-up.
- Published in:
- European Journal of Clinical Pharmacology, 2003, v. 58, n. 10, p. 689, doi. 10.1007/s00228-002-0548-0
- By:
- Publication type:
- Article
9
Determinants for drug prescribing to children below the minimum licensed age.
- Published in:
- European Journal of Clinical Pharmacology, 2003, v. 58, n. 10, p. 701, doi. 10.1007/s00228-002-0554-2
- By:
- Publication type:
- Article
10
Transplacental passage of lamotrigine in a human placental perfusion system in vitro and in maternal and cord blood in vivo.
- Published in:
- European Journal of Clinical Pharmacology, 2003, v. 58, n. 10, p. 677, doi. 10.1007/s00228-002-0544-4
- By:
- Publication type:
- Article
11
A clinical study investigating the pharmacokinetic interaction between NN703 (tabimorelin), a potential inhibitor of CYP3A4 activity, and midazolam, a CYP3A4 substrate.
- Published in:
- European Journal of Clinical Pharmacology, 2003, v. 58, n. 10, p. 683, doi. 10.1007/s00228-002-0539-1
- By:
- Publication type:
- Article
12
Effect of ciprofloxacin on the pharmacokinetics of ropivacaine.
- Published in:
- European Journal of Clinical Pharmacology, 2003, v. 58, n. 10, p. 653, doi. 10.1007/s00228-002-0540-8
- By:
- Publication type:
- Article
13
Use of calcium antagonists and worsening renal function in patients receiving angiotensin-converting-enzyme inhibitors.
- Published in:
- European Journal of Clinical Pharmacology, 2003, v. 58, n. 10, p. 695, doi. 10.1007/s00228-002-0555-1
- By:
- Publication type:
- Article
14
Low plasma cefaclor levels in cystectomized bladder cancer patients with various types of urinary diversion.
- Published in:
- European Journal of Clinical Pharmacology, 2003, v. 58, n. 10, p. 715, doi. 10.1007/s00228-002-0536-4
- By:
- Publication type:
- Article